Patent · US Active

Vaccination in newborns and infants

US10596252B2 · kind B2 · utility

24Cited by

2References

19Claims

0Family size

Assignee

CureVac AG · DE

Inventors

Karl-Josef Kallen · Tübingen, DE
Thomas Kramps · Bellinzona, CH
Margit SCHNEE · Konstanz, DE
Benjamin PETSCH · Tübingen, DE
Lothar Stitz · Rottenburg am Neckar, DE

Key dates

Filing date	Nov 4, 2018
Grant date	Mar 24, 2020
Priority date	—
Expiry date	Nov 4, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to vaccines comprising at least one mRNA encoding at least one antigen for use in the treatment of a disease in newborns and/or infants, preferably exhibiting an age of not more than 2 years, preferably of not more than 1 year, more preferably of not more than 9 months or even 6 months, wherein the treatment comprises vaccination of the newborn or infant and eliciting an immune response in said newborn or infant. The present invention is furthermore directed to kits and kits of parts comprising such a vaccine and/or its components and to methods applying such a vaccine or kit.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.